Four-stranded helix identified in human cells

Quadruplexes may turn instrumental in devising new targeted therapies

Sixty years ago, a research paper was published which was the first to describe the double-helix DNA structure.

Photo: Four-stranded helix identified in human cells

That discovery had been made by James Watson and Francis Crick from the University of Cambridge in the UK. After ten years of investigations, researchers from the same university have now gone public with a paper proving the existence of quadruple structures in the human genome (http://www.cam.ac.uk/research/news/four-stranded-quadruple-helix-dna-structure-proven-to-exist-in-human-cells/). The work, published in Nature Chemistry, shows links between concentrations of four-stranded quadruplexes and DNA replication, which plays a key role in cell division and production.

Scientists believe that targeting quadruplexes with synthetic molecules which trap and contain these DNA structures can prevent cells from replicating their DNA, blocking cell division and halting cell proliferation at the root of cancer. The research „indicates that quadruplexes are more likely to occur in genes of cells that are rapidly dividing, such as cancer cells“, said Prof. Shankar Balasubramanian whose group produced the research. According to the expert from the University of Cambridge’s Department of Chemistry and Cambridge Research Institute, four-stranded structures and their potential for targeted cancer treatment are to serve as a new paradigm for investigation.  (Michael Reiter)

30.01.2013

More on the subject:

Related articles

Photo

News • Signs of life

BCI could help comatose patients communicate

A new study opens the door to noninvasive brain-computer interfaces that could allow seemingly comatose patients in the ICU with hidden consciousness to communicate with doctors and family members.

Photo

News • Preclinical study

Lung cancer: new approach to reduce radiation-related damage

Radiotherapy can be lifesaving for patients with lung cancer, but may also damage healthy lung tissue and limit future treatments. Discovery of a new immune pathway could help prevent this damage.

Photo

News • Molecular imaging

HER2-positive breast cancer: PET/CT technique shows promise for predicting treatment response

Molecular imaging with ⁶⁸Ga-HER2 PET/CT may provide an early, targeted measure of how well treatment is working in patients with HER2-positive breast cancer, according to new research.

Subscribe to Newsletter